StonvexLoading…
StonvexCore line items from SPGI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.17B | $15.34B | $11.42B | $7.53B |
Operating Income | $2.00B | $6.48B | $4.80B | $3.13B |
Net Income | $1.40B | $4.47B | $3.34B | $2.16B |
EPS (Diluted) | $4.69 | $14.66 | $10.90 | $7.04 |
Total Assets | $60.79B | $61.20B | $59.75B | $60.40B |
Total Liabilities | $24.59B | $25.05B | $22.05B | $22.43B |
Cash & Equivalents | $1.81B | $1.75B | $1.67B | $1.85B |
Free Cash Flow OCF − CapEx | $1.01B | $5.46B | $3.75B | $2.29B |
Shares Outstanding | 296.00M | 298.80M | 303.40M | 305.30M |